NCT00704119 - Study Evaluating the Pharmacokinetic Profile of RhuDex® in a Tablet Formulation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

August 31, 2008

Conditions

Pharmacokinetics

Interventions

DRUG

RhuDex®

"* Treatment A.1: 31.65 mg RhuDex® once N=12~* Treatment A.2: 63.33 mg RhuDex® once N=12~* Treatment A.3: 126.63 mg RhuDex® once N=12~* Treatment A.4: 253.26 mg RhuDex® once N=12~* Treatment B.1: 31.65 mg RhuDex® once N=12~* Treatment B.2: selected dose of RhuDex® once N=12~* Treatment C: selected dose of RhuDex® once N=12~* Treatment D: selected dose of RhuDex® twice daily for 6 days N=12"

Trial Locations (1)

EH14 4AP

Charles River Clinical Services Edinburgh Ltd, Edinburgh